Sky's James Sillars writes that a government, struggling for authority and prioritising economic growth, can not afford to ...

AstraZeneca reported earnings per share of $4.03, a year-over-year increase of 5%. In this way, Soriot said, the company is able to better "manage the turbulences" of the geopolitical landscape.

AstraZeneca (AZN, Financials) is weighing a move from London to a U.S. stock exchange; a shift that would mark a blow to the ...

Pascal Soriot, Chief Executive Officer, AstraZeneca, said: "Our strong growth momentum has continued into 2025 and we have now entered an unprecedented catalyst-rich period for our company ...

The Bengaluru hub will play a central role in AstraZeneca’s global strategy to deliver 20 new medicines by 2030, the company said. The investment is aimed at building scalable, data-driven, and ...

AstraZeneca completed a $300 million, 84,000 square-foot facility in Rockville that will focus on the manufacturing of CAR-T cell therapies to enable cancer clinical trials to be conducted globally.